SOURCE: 340B Prime Vendor Program

April 18, 2007 13:15 ET

HPPI Receives Contract Extension From HRSA for 340B Prime Vendor Program

IRVING, TX -- (MARKET WIRE) -- April 18, 2007 -- The 340B Prime Vendor Program, managed by Healthcare Purchasing Partners International (HPPI), has received a contract extension from the Health Resources and Services Administration (HRSA).

On September 10, 2004, HRSA awarded a contract to HPPI to serve as the Prime Vendor for the 340B Drug Pricing Program. The agreement was awarded for two years plus three one-year options. HRSA has extended the agreement through September 9, 2008 with a one-year option remaining.

"We are delighted that the contract has been extended. The contract extension enables us to continue to provide sub-ceiling discounts on outpatient drugs and discounts on other outpatient pharmacy products and services to our participating hospitals, clinics, and other HRSA grantees treating the nation's low-income and uninsured," said Chris Hatwig, senior director, 340B Program.

340B Prime Vendor Program

The Prime Vendor Program was established to increase the discounts already offered under Section 340B of the U.S. Public Health Service Act, providing low-cost drugs to clinics, hospitals and programs for low-income Americans. Over 12,000 providers across the country qualify to participate in the discount program at no cost, and more than 4,600 facilities are currently enrolled. HealthCare Purchasing Partners International, an Irving, Texas-based health care group purchasing organization co-owned by VHA Inc. and the University Health System Consortium, administers the program. Visit the Section 340B Prime Vendor Program Web site at http://www.340bpvp.com/ for more information about the program.

Contact Information